A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences
- PMID: 17607330
- PMCID: PMC1896312
- DOI: 10.4088/pcc.v09n0202
A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences
Abstract
Objective: Clinical guidelines recommend that antidepressant treatment should be continued for a minimum of 6 months following response in depression and anxiety disorders. However, adherence to antidepressants is low. This prospective cohort study investigated the influence of patients' antidepressant concerns, treatment preferences, and illness perceptions on adherence to antidepressants over a 6-month period.
Method: A cohort of 178 patients aged 18 to 74 years and newly issued with a prescription for antidepressants to treat any condition was followed up prospectively at 5 primary care practices in Southeast England. Adherence was measured through self-report and prescription refill data. Patient perceptions were quantified using validated outcome measures, the Beliefs about Medicine Questionnaire and the Illness Perception Questionnaire, at 4 timepoints. Patient treatment preferences were recorded using a specially designed questionnaire. Data collection took place between September 2000 and May 2002.
Results: Of 147 participants (83%) who completed the study, 19% persisted with antidepressants in accordance with guideline recommendations throughout the 6-month period. Specific concern about antidepressant side effects (OR = 3.30, 95% CI = 2.20 to 4.97) and general worry about taking antidepressants (OR = 1.65, 95% CI = 1.13 to 2.40) were independent predictors of antidepressant nonuse. Preference for different treatment/uncertainty about preferred treatment was also a strong predictor (OR = 3.82, 95% CI = 1.35 to 10.77). However, illness perceptions were not associated with adherence.
Conclusions: Concerns about antidepressants and a mismatch between patients' preferred and prescribed treatment act as significant barriers to sustained adherence. This study highlights the central role of the patient-physician partnership in exploring antidepressant concerns, working with treatment preferences, and providing supportive continued management. The findings may inform the development of interventions within primary care programs to enhance commitment to treatment for common mental disorders.
Figures
Similar articles
-
[Antidepressants consumption in the global population in France].Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. Encephale. 2002. PMID: 12386542 French.
-
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005. CNS Drugs. 2008. PMID: 18840035
-
The role of the primary care physician in patients' adherence to antidepressant therapy.Med Care. 1995 Jan;33(1):67-74. doi: 10.1097/00005650-199501000-00006. Med Care. 1995. PMID: 7823648
-
Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care.Int J Geriatr Psychiatry. 2002 Aug;17(8):752-7. doi: 10.1002/gps.688. Int J Geriatr Psychiatry. 2002. PMID: 12211126
-
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.Cochrane Database Syst Rev. 2019 Apr 12;4(4):CD012680. doi: 10.1002/14651858.CD012680.pub2. Cochrane Database Syst Rev. 2019. PMID: 30977111 Free PMC article.
Cited by
-
Factors associated with antidepressant medication adherence and adherence-enhancement programmes: a systematic literature review.Ment Health Fam Med. 2011 Dec;8(4):255-71. Ment Health Fam Med. 2011. PMID: 23205067 Free PMC article.
-
Translating comparative effectiveness of depression medications into practice by comparing the depression medication choice decision aid to usual care: study protocol for a randomized controlled trial.Trials. 2013 May 7;14:127. doi: 10.1186/1745-6215-14-127. Trials. 2013. PMID: 23782672 Free PMC article. Clinical Trial.
-
Cognitive behavioural therapies versus other psychological therapies for depression.Cochrane Database Syst Rev. 2010;(9):CD008698. doi: 10.1002/14651858.CD008698. Cochrane Database Syst Rev. 2010. PMID: 25411559 Free PMC article.
-
Mindfulness-based 'third wave' cognitive and behavioural therapies versus treatment as usual for depression.Cochrane Database Syst Rev. 2010 Sep 8;(9):CD008705. doi: 10.1002/14651858.CD008705. Cochrane Database Syst Rev. 2010. PMID: 25067907 Free PMC article.
-
Should treatment for depression be based more on patient preference?Patient Prefer Adherence. 2013 Oct 9;7:1047-57. doi: 10.2147/PPA.S52746. eCollection 2013. Patient Prefer Adherence. 2013. PMID: 24143080 Free PMC article. Review.
References
-
- Schulberg HC, Katon W, and Simon GE. et al. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry. 1998 55:1121–1127. - PubMed
-
- National Institute for Clinical Excellence. NICE guidelines to improve the treatment and care of people with depression and anxiety. Available at: www.nice.org.uk. Accessed Dec 17, 2004.
-
- Fairman KA, Drevets WC, and Kreisman JJ. et al. Course of antidepressant treatment drug type, and prescriber's specialty. Psychiatr Serv. 1998 49:1180–1186. - PubMed
-
- Olfson M, Marcus SC, and Tedeschi M. et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006 163:101–108. - PubMed
-
- Bull SA, Hunkeler EM, and Lee JY. et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother. 2002 36:578–584. - PubMed
LinkOut - more resources
Full Text Sources